China Grand Pharmaceutical and Healthcare Holdings Limited announced unaudited earnings guidance for the six months ended June 30, 2018. The company expected that the unaudited consolidated net profit attributable to owners of the Company recorded an increase of not less than 50% as compared to that of the six months ended 30 June 2017 (the unaudited consolidated net profit attributable to owners of the Company for the six months ended 30 June 2017 amounted to approximately HKD 205,905,000).